PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-5

  1. 14,657 Posts.
    lightbulb Created with Sketch. 1583
    Hi Monti

    Yes, it’s more about the goodwill.
    Nobody knows who is on active and who is on placebo, so any sense of how the treatment is performing is, at best, an overall sense.

    The trial design guarantees that those on Placebo will get Avicursen after getting the Placebo for 6 months..
    It’s more to do with people to enroll in the trial

    Also imo the 9 month data will be better ..

    All those after the 12 month sturdy will carry on with Avicursen if desired…
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.